Atlas Trials

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

Clinical trial NCT06880198 · RECRUITING

Trial details

NCT number
NCT06880198
Sponsor
Fondazione Melanoma Onlus
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Melanoma MetastaticLocally Advanced Melanoma
Start date
2024-08-01
Primary completion
2027-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.